Answers are grounded in this paper and cite their sources.
EDITOR: Following the introduction of rocuronium bromide into clinical practice, several articles concerning allergic reactions have been published [1]. We would like to describe a life-threatening reaction after rocuronium followed by dysrhythmias, profound hypotension and stroke. A 45-yr-old female was admitted for an elective gynaecological procedure because of cervical intra-epithelial neoplasia (CIN 2-3). As a child she had a heart murmur but had never experienced cardiovascular problems. Preoperative physical examination, laboratory findings, electrocardiogram (ECG) and chest X-ray were all normal. She had never undergone surgery or anaesthesia before. Due to mild arthritis, she took an occasional ibuprofen tablet. Neither she nor any member of her family had ever had an allergic reaction to food or drugs. Two hours before surgery, she received dalteparine-sodium 0.3 mL subcutaneously followed by atropine 0.5 mg and midazolam 5 mg intramuscularly 30 min before surgery. An intravenous (i.v.) cannula was inserted in the operating room and routine monitoring applied. Anaesthesia was induced with 15 mg of midazolam and 0.1 mg of fentanyl followed after 2 min by 40 mg of rocuronium bromide (a routine technique in our hospital). The patient was ventilated with 100% oxygen via a facemask. Immediately after injection of the rocuronium, systolic blood pressure (systolic BP) fell to 60 mmHg and heart rate (HR) to 30 beats min−1. Atropine sulphate 1.0 mg was given in two divided doses. At the same time an erythematous reaction appeared on her forearm and around the i.v. cannula followed by generalized urticaria. Anaphylaxis was suspected and epinephrine 1 mg, methylprednisolone 250 mg and chloropyramine 20 mg (an antihistamine) were immediately given i.v. An additional i.v. cannula was inserted and i.v. fluid administered rapidly. The ECG initially showed a tachycardia of 160 beats min−1 with elevation of the ST segment followed by fast atrial fibrillation with a rapid ventricular response. Generalized angioedema, piloerection and skin cyanosis appeared on the limbs. There was no bronchospasm. A marked acidosis (pH 7.1) was recorded and the oxygen saturation fell to 33% at one point. After approximately 10 min an enlarged pupil of the left eye was noted but the pupils were equal again 5 min later. An i.v. infusion of dobutamine was started and the BP gradually rose to a systolic BP of 60 mmHg. The atrial fibrillation was converted to sinus rhythm by verapamil 5 mg followed by a further 5 mg 10 min later. Tachydysrhythmias with occasional ventricular premature beats continued with a HR of 120 beats min−1. The surgical procedure was postponed and the patient transferred to the intensive care unit. Her BP was now 145/85 mmHg with a HR of 120 beats min−1. The next day she had stable vital functions and the ECG was normal but neurological examination revealed a right-sided hemiplegia, head and neck deviation to the left side and aphasia. A stroke of the thalamic area was suspected although computed tomography and magnetic resonance imaging of the brain did not show any visible lesions. Doppler ultrasound scan of the brain vessels showed no localized stenosis. After neurological treatment and prolonged physical therapy the patient made a complete recovery. Six months later, the patient underwent intradermal allergy testing to rocuronium, midazolam, fentanyl and placebo all at 1 : 20 dilutions. Rocuronium was positive, the rest were all negative. Cross-sensitivity tests to other muscle relaxants were not undertaken. Although the recommended time for skin testing is 6 weeks after the reaction, this was not possible due to circumstances beyond our control. Mast cell tryptase measurements were unfortunately not taken because the facility does not exist in our hospital to perform this measurement. Despite these limitations, we believe that this was an anaphylactic reaction to the rocuronium. Anaphylactic reactions during anaesthesia are rare but may have dramatic and unpredictable consequences. Amongst the drugs used during anaesthesia, muscle relaxants have a high incidence of developing allergic reactions [2] with an incidence of 1 : 6500. Seventy percent of patients with a positive allergic reaction to one muscle relaxant show cross-sensitivity reactions to other muscle relaxants from that group [3]. It seems to be more common in females aged 20-40 yr. The mortality rate is about 3-4%. The mechanism behind anaphylactic reactions is immunologic and related to the formation of specific IgE antibodies. The usual technique for confirming allergy is the prick or intradermal test. The further use of muscle relaxants selected by negative intradermal tests has been proven to be safe [2]. Profound and prolonged hypotension is an uncommon side-effect of this group of drugs and has been attributed to ganglion blockade [4]. It is known that an anaphylactic reaction can develop in patients who have never undergone prior exposure to an agent. A possible explanation here might be the sensitization through the use of cosmetics and soaps which also contain the quaternary ammonium ion [5]. Following an allergic reaction, doctors must fully inform their patients about the situation [5]. Tests including all drugs to which the patient was exposed should be obtained 4-8 weeks after the incident occurred with particular attention to cross sensitivity [6]. Investigations should be performed to confirm the nature of the reaction if possible, which of the suspected drugs were responsible and to provide recommendations to the patient for future anaesthetic procedures. All side-effects should be recorded. Contacts with colleagues and reports to National centres for adverse reactions must also become a part of routine practice. G. Brozovic S.
No takes yet. Share an insight, caveat, or question.
Brozović et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: